Maldives vs Sudan: Access to anti-retroviral drugs, female
Maldives
21.0%
in 2024
Sudan
19.0%
in 2024
Maldives rank
138th
Sudan rank
140th
Access to anti-retroviral drugs, female over time
- Maldives
- Sudan
How they compare
Maldives currently reports 21.0% against 19.0% in Sudan, a difference of 2.0%.
That makes Maldives's figure about 1.1 times Sudan's.
The two have swapped places 5 times across 22 shared years of data; in 2000 it was Sudan ahead.
Maldives ranks 138th and Sudan ranks 140th of 141 countries.
Across the 3 decades both report, Maldives averaged higher in 1 and Sudan in 2.
Head to head by decade
| Decade | Maldives | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.0% | 1.6% | 6.4% | Maldives |
| 2010s | 8.4% | 14.5% | 6.1% | Sudan |
| 2020s | 20.2% | 23.4% | 3.2% | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Maldives or Sudan?
- Maldives, at 21.0% against 19.0% in Sudan as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Maldives and Sudan?
- 2.0%, with Maldives ahead.
- How many years of comparable data are there for Maldives and Sudan?
- 22 years are reported by both, from 2000 to 2024.
- How do Maldives and Sudan rank globally for access to anti-retroviral drugs, female?
- Maldives ranks 138th and Sudan ranks 140th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.